Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Malama Health Secures $9.2M to Scale Doula-Led Maternal Care for Medicaid-Insured Women Nationwide
Oversubscribed Seed Round Led by Acumen America Accelerates Malama Health’s Mission to Build the National Infrastructure for Continuous, Doula-Led Care Across Pregnancy and Postpartum
Malama Health, a Medicaid-first maternal health company, today announced an oversubscribed $9.2 million seed round led by Acumen America, with participation from Wisdom Ventures, Capital F, and Coyote Ventures, alongside angels from the company’s pre-seed round. The raise includes a $2.3 million NIH grant and more than $1 million in California state funding, reflecting alignment from federal and state stakeholders alongside venture capital. The capital will expand Malama Health’s care network across Medicaid markets, grow its Doula-Care Navigator workforce, and deepen managed care and community health center partnerships.
Modern maternity care was not designed for continuous support. Research shows that labor and delivery nurses are constrained to spend just 6-10% of their time on comfort measures and emotional support, far below the 53% that mothers expect. Women with continuous physical, emotional, and mental support through labor and into the postpartum period require fewer interventions and experience better outcomes – and for most Medicaid-insured women, who represent more than 40% of U.S. births, that support has never existed. The postpartum period is where most pregnancy-related deaths occur, yet the standard of care offers little beyond a single six-week visit.
Malama Health was built from day one to address birth equity and high-risk pregnancies. Its multilingual, EHR-connected patient-facing app delivers accessible technology and educational content written at a fifth-grade literacy level, meeting women where they are. Doula care navigators are embedded within communities, working alongside clinician oversight, remote biometric monitoring (glucose, blood pressure, weight), and managed care coordination in a single connected model. Doulas attend births, conduct home visits, navigate between appointments, escalate clinical risk signals in real-time, and remain engaged through the full postpartum year.
“Women in this country are trying to navigate a sick care system that was never designed for them. Most get a handful of prenatal appointments and one postpartum visit, and then they’re on their own,” said Mika Eddy, Co-Founder and CEO at Malama Health. “We built Malama to be the support system they should have had from the start.”
Patient-reported outcomes data from more than 2,500 women show a 6% decrease in NICU admissions, a 9% decrease in C-section rates, and a 38% decrease in preterm birth rates. A randomized controlled trial conducted at Tufts Medical Center found that women who used Malama during pregnancy were significantly less likely to develop diabetes, reporting a 40% difference in postpartum diabetes outcomes versus standard care.
“Health equity in maternal care requires trust,” said Veenu Aulakh, Director at Acumen America…
Full release here, originally announced March 12th, 2026.
Nitra Raises $187 Million as AI-Native Platform for Healthcare Practices Surpasses $1 Billion in Processing Volume
Revenues Grew 8x in 2025 and Targets $4 Billion in Annualized Processing Volume in 2026
CityMD Founder Dr. Richard Park Joins Board
Nitra, the leading AI-native, all-in-one operating platform for healthcare practices and their back offices, today announced $187 million in financing across its Series A and Series B rounds, venture debt, and warehouse facility, bringing the company’s total capital raised to $205 million and total equity raised to $90 million.
The funding follows a breakout year for Nitra, which grew revenues 740%+ in 2025, surpassing $1 billion in annualized processing volume as healthcare practices increasingly expand uses of AI beyond clinical decision support and scribing into administration, finances, and inventory, and the back office.
The financing includes $72 million of new equity across a $50 million Series B round and a previously unannounced $22 million Series A completed in August 2025 from investors including Actions Capital, AppWorks, Comma Capital, Dunamu & Partners, Era Funds, New Enterprise Associates (NEA), Pantera Capital, and Sazze Partners.
The financing also included participation from AAF, Gaingels, Hyphen Capital, K8, Mana Ventures, Necessary Ventures, PIDC/Uni-President, Purestone Silks, SignalRank, Simu Liu’s Markham Valley Ventures, Soma Capital, and others.
The company also secured $20 million in venture debt from Avenue Capital Group and an expanded $95 million warehouse facility from Treville Capital Group and Encina Lender Finance, LLC.
Dr. Richard Park, Founder and former CEO at CityMD, joined Nitra’s Board of Directors. CityMD merged with Summit Health, and the combined company was acquired by VillageMD (owned by Walgreens) for $8.9 billion in 2023…
Full release here, originally announced March 10th, 2026.
No comments:
Post a Comment